Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol

por Maksymowych, Walter P., Kumke, Thomas, Auteri, Simone E., Hoepken, Bengt, Bauer, Lars, Rudwaleit, Martin
Publicado 2021

Certolizumab pegol treatment in axial spondyloarthritis mitigates fat lesion development: 4-year post-hoc MRI results from a phase 3 study

por Baraliakos, Xenofon, Kruse, Sebastian, Auteri, Simone E, de Peyrecave, Natasha, Nurminen, Tommi , Kumke, Thomas, Hoepken, Bengt, Braun, Jürgen
Publicado 2021

Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review

por Baraliakos, Xenofon, Gensler, Lianne S., D’Angelo, Salvatore, Iannone, Florenzo, Favalli, Ennio G., de Peyrecave, Natasha, Auteri, Simone E., Caporali, Roberto
Publicado 2020

Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons

por Akkoç, Nurullah, Arteaga, Carlos H., Auteri, Simone E., Betts, Marissa, Fahrbach, Kyle, Kim, Mindy, Kiri, Sandeep, Neupane, Binod, Gaffney, Karl, Mease, Philip J.
Publicado 2023

Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA

por Frasca, Loredana, Palazzo, Raffaella, Chimenti, Maria S., Alivernini, Stefano, Tolusso, Barbara, Bui, Laura, Botti, Elisabetta, Giunta, Alessandro, Bianchi, Luca, Petricca, Luca, Auteri, Simone E., Spadaro, Francesca, Fonti, Giulia L., Falchi, Mario, Evangelista, Antonella, Marinari, Barbara, Pietraforte, Immacolata, Spinelli, Francesca R., Colasanti, Tania, Alessandri, Cristiano, Conti, Fabrizio, Gremese, Elisa, Costanzo, Antonio, Valesini, Guido, Perricone, Roberto, Lande, Roberto
Publicado 2018